Solstice Advanced Materials
Supplies refrigerants and specialty materials for cooling, semiconductors, healthcare, defense, and laboratories.
Something off on this page? Send us feedback.
Profile
Supplies low-global-warming-potential refrigerants, semiconductor materials, protective fibers, healthcare packaging, and laboratory chemicals through two segments. Refrigerants & Applied Solutions generates most sales, while the business serves customers worldwide and depends on regulation, customer qualifications, manufacturing performance, and continued innovation.
Supplies low-global-warming-potential refrigerants, blowing agents, solvents, aerosol materials, nuclear conversion services, and healthcare packaging through Refrigerants & Applied Solutions. Electronic & Specialty Materials provides semiconductor materials, protective fibers, and high-purity laboratory and life-science products.
Serves customers across about 120 countries and territories, pairing application-specific materials with brands including Solstice, Genetron, Aclar, Spectra, Fluka, and Hydranal. The inherited portfolio combines long-established industrial operations with a newly independent public-company structure.
Growth and product mix depend on refrigerant regulation, continued innovation, customer qualifications, and manufacturing performance. Standalone systems remain a post-separation requirement, while the announced Element Solutions acquisition is still subject to shareholder, regulatory, and other closing conditions.
Company facts
Key statistics
Year to date +29.0% · Average volume (30d) 3.2M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | RBC Capital | Reiterate | Outperform | $102 | $82 | |
| Jul 31, 2026 | UBS | Reiterate | Buy | $78 | $80 | |
| Jul 22, 2026 | Vertical Research | Upgrade | Hold | Buy | $90 | $79 |
| Jul 14, 2026 | Mizuho Securities | Target | $95 | $70 | ||
| Jul 13, 2026 | UBS | Upgrade | Neutral | Buy | $88 | $78 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $0.77 | $0.88 | +13.7% | $1.08B | $1.15B | +6.4% | +3.11% |
| May 6, 2026Q1 FY26 | $0.60 | $0.63 | +5.0% | $973.9M | $991.0M | +1.8% | −5.18% |
| Feb 11, 2026Q4 FY25 | $0.40 | $0.26 | −35.0% | $921.6M | $987.0M | +7.1% | +4.11% |
| Nov 6, 2025Q3 FY25 | $0.36 | −$0.22 | −161.5% | $924.4M | $969.0M | +4.8% | +5.49% |
Financial highlights
| 9 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $897.0M | $1.03B | $969.0M | $987.0M | $991.0M | $1.15B | |
| Gross profit | $321.0M | $357.0M | $310.0M | $258.0M | $316.0M | $370.0M | |
| Operating income | $206.0M | $215.0M | $171.0M | $119.0M | $180.0M | $222.0M | |
| Net income | $134.0M | $16.0M | −$35.0M | $41.0M | $85.0M | $119.0M | |
| Diluted EPS | $0.73 | $0.73 | −$0.22 | $0.26 | $0.53 | $0.75 | |
| Gross margin | 35.8% | 34.6% | 32.0% | 26.1% | 31.9% | 32.2% | |
| Operating margin | 23.0% | 20.8% | 17.6% | 12.1% | 18.2% | 19.3% |
Fiscal years (4-quarter sums)FY25 $3.89B
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $750.0M · Total debt $2.41B · Total assets $5.92B · Shareholders' equity $1.59B
Dividends
To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 27, 2026 | Aug 27 | Sep 10 | $0.075 | |
| May 27, 2026 | May 27 | Jun 10 | $0.075 | |
| Feb 24, 2026 | Feb 24 | Mar 10 | $0.075 |
Ownership
Shares outstanding 158.85M · Float 82.92M · 52.2% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.93M | 10.03% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 7.94M | 5.00% | 13F | Aug 13, 2026 |
| Vanguard Capital Management LLC | 7.17M | 4.52% | 13F | Aug 13, 2026 |
| State Street Corp | 5.06M | 3.19% | 13F | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 3.54M | 2.23% | 13F | Aug 14, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
- Chemours
Closest rival across low-GWP refrigerants and foam solutions
- Entegris
Semiconductor process-materials rival serving advanced fabs
- Avient
Direct UHMWPE-fiber rival in lightweight ballistic protection
